Evaluation of Hematological, Inflammatory and Coagulation Biomarkers as an Indicator of COVID-19 Severity

被引:0
|
作者
AYDIN, Nurten Nur [1 ]
AYDIN, Murat [1 ]
YILMAZ, Sibel I. B. A. [1 ]
机构
[1] Erzurum Reg Training & Res Hosp, Clin Infect Dis & Clin Microbiol, Erzurum, Turkiye
来源
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI | 2023年 / 28卷 / 02期
关键词
COVID-19; Biomarker; Lymphocyte-CRP ratio (LCR); Fibrinogen-albumin ratio (FAR); DISEASE SEVERITY; PARAMETERS; INFECTION; MARKERS;
D O I
10.5578/flora.20239918
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction: The aim of this study is to investigate the relationship between the severity of coronavirus disease-19 (COVID-19) with hematological, biochemical and coagulation parameters. Materials and Methods: This study included 277 hospitalized patients who were diagnosed with COVID-19 by realtime polymerase chain reaction (PCR) analysis of nasopharyngeal swab sample between January and May 2021. According to the World Health Organization (WHO) COVID-19 severity classification, patients were divided into two groups as mild/moderate group (non-severe) and severe/critical group (severe). Demographic data of the patients and laboratory parameters at the time of hospitalization were evaluated retrospectively. Results: The neutrophil count was significantly higher in the severe group (p= 0.021), while the lymphocyte and thrombocyte counts were significantly lower (p< 0.001, p= 0.031, respectively). Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, mean platelet volume-lymphocyte ratio were significantly higher in the severe group (p< 0.001, p= 0.001, p< 0.001, respectively), while lymphocyte-monocyte ratio was lower (p= 0.005). C-reactive protein (CRP), ferritin, D-dimer, fibrinogen and prothrombin time were significantly higher in the severe group (p< 0.001, p< 0.001, p= 0.004, p< 0.001, p= 0.033, respectively), albumin levels were lower (p< 0.001). Blood urea nitrogen-albumin ratio, CRP-albumin ratio, fibrinogen-albumin ratio (FAR) were significantly higher and lymphocyte-CRP ratio (LCR) was lower in the severe group (p< 0.001 for each). The area under the curve (AUC) of the LCR value was 0.747 in ROC analyzes performed between both groups. When the LCR cut-off value was 0.14, 86.9% sensitivity and 52.9% specificity were detected. When the cut-off value of CRP was 13.2 mg/L, 0.724 AUC was detected with 82.0% sensitivity and 57.1% specificity. FAR showed 59.3% sensitivity and 72.2% specificity at a cut-off value of 12.17 (AUC= 0.696). Ferritin showed 72.7% sensitivity and 55.6% specificity at a cut-off value of 189 ng/mL (AUC= 0.691). A strong correlation was found between FAR and CRP in the correlation analysis (r= 0.724, p< 1000). In addition, a relationship was found between FAR and ferritin (r= 0.454, p< 1000). Conclusion: These laboratory parameters can be used as suitable biomarkers to determine the severity of COVID-19. These can help clinicians identify potentially serious cases at an early stage and enable early medical management.
引用
收藏
页码:188 / 197
页数:10
相关论文
共 50 条
  • [1] Hematological, Inflammatory, Coagulation, and Oxidative/Antioxidant Biomarkers as Predictors for Severity and Mortality in COVID-19: A Prospective Cohort-Study
    Smail, Shukur Wasman
    Babaei, Esmaeil
    Amin, Kawa
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 565 - 580
  • [2] Evaluation of inflammatory and hematological parameters in patients diagnosed with COVID-19
    Mermutluoglu, Cigdem
    Dursun, Recep
    Aktar, Fesih
    Dayan, Saim
    Celen, Mustafa Kemal
    Kadiroglu, Ali Kemal
    Inci, Erdal
    Karagoz, Rengin
    Kuyumcu, Mahir
    Ozcan, Nida
    Tekin, Recep
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2022, 16 (10): : 1564 - 1569
  • [3] Evaluation of hematological parameters as an indicator of disease severity in Covid-19 patients: Pakistan's experience
    Waris, Abdul
    Din, Misbahud
    Khalid, Atiqa
    Lail, Raees Abbas
    Shaheen, Asmat
    Khan, Nida
    Nawaz, Mehboob
    Baset, Abdul
    Ahmad, Imtiaz
    Ali, Muhammad
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (06)
  • [4] Inflammatory, Hematological, and Biochemical Biomarkers in COVID-19 Patients
    Ayako, Rebeccah M.
    Patel, Kirtika
    Ndede, Isaac
    Nordgren, Johan
    Larrson, Marie
    Mining, Simeon K.
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (12)
  • [5] Clinical Value of Inflammatory Biomarkers in Determining Severity of COVID-19
    Gulacti, Umut
    Lok, Ugur
    Aydin, Irfan
    Turgut, Kasim
    Yavuz, Erdal
    Kaya, Hakan
    Kafadar, Huseyin
    Arslan, Ebru
    Sonmez, Cihad
    Algin, Abdullah
    Kurt, Ercan
    Ozdin, Mehmet
    Yucetas, Seyho Cem
    JOURNAL OF ACUTE MEDICINE, 2023, 13 (02) : 58 - 64
  • [6] Association Between Metabolic Syndrome Inflammatory Biomarkers and COVID-19 Severity
    Pham, Thaidan T.
    Zu, Yuanhao
    Ghamsari, Farhad
    Oh, Janice
    Mauvais-Jarvis, Franck
    Zheng, Hui
    Filbin, Michael
    Denson, Joshua L.
    JOURNAL OF THE ENDOCRINE SOCIETY, 2023, 7 (05)
  • [7] Hematological, inflammatory, and novel biomarkers assessment as an eminent strategy for clinical management of COVID-19
    Rezaeian, Sanaz
    Razmjooei, Fatemeh
    Pourmokhtari, Masoome
    Abdoli, Amir
    Jahromi, Mirza Ali Mofazzal
    Bagheri, Kambiz
    HELIYON, 2023, 9 (12)
  • [8] Evaluation of Biomarkers of Severity in Patients with COVID-19 Infection
    Yamamoto, Akitaka
    Wada, Hideo
    Ichikawa, Yuhuko
    Mizuno, Hikaru
    Tomida, Masaki
    Masuda, Jun
    Makino, Katsutoshi
    Kodama, Shuji
    Yoshida, Masamichi
    Fukui, Shunsuke
    Moritani, Isao
    Inoue, Hidekazu
    Shiraki, Katsuya
    Shimpo, Hideto
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [9] Hematological findings in COVID-19 and their correlation with severity of Disease
    Mahmood, Namra
    Riaz, Zahra
    Sattar, Arooj
    Kiran, Mehwish
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2023, 39 (03) : 795 - 798
  • [10] Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection
    Lopez-Castaneda, Sandra
    Garcia-Larragoiti, Nallely
    Cano-Mendez, Alan
    Blancas-Ayala, Kenia
    Damian-Vazquez, Guadalupe
    Itzel Perez-Medina, Ana
    David Chora-Hernandez, Luis
    Arean-Martinez, Carlos
    Eva Viveros-Sandoval, Martha
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27